CCMU
AUPH icon

Cheyne Capital Management (UK)’s Aurinia Pharmaceuticals AUPH Stock Holding History

Cheyne Capital Management (UK)’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-90,000
Closed -$257K – 35
2015
Q3 		$257K Hold
90,000
– – 0.12% 38
2015
Q2 		$274K Hold
90,000
– – 0.09% 81
2015
Q1 		$401K Hold
90,000
– – 0.1% 59
2014
Q4 		$323K Sell
90,000
-16,805
-16% -$59.8K 0.08% 54
2014
Q3 		$347K Buy
+106,805
New +$380K 0.12% 45

Other funds holding AUPH

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Cheyne Capital Management (UK)'s AUPH Position: Q4 2015 in Review

Cheyne Capital Management (UK) sold out of Aurinia Pharmaceuticals (AUPH) in Q4 2015, closing a stake of 90,000 shares — an estimated $257K sold.

Cheyne Capital Management (UK) first reported a position in AUPH in Q3 2014 and held it in 5 quarters. The position peaked at $401K in Q1 2015. 16 funds tracked by Wall St. Rank hold AUPH as of Q4 2015.

  • Cheyne Capital Management (UK) reported no remaining Aurinia Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • Cheyne Capital Management (UK) sold 90,000 Aurinia Pharmaceuticals shares in Q4 2015, an estimated $257K.
  • Cheyne Capital Management (UK) first reported a position in Aurinia Pharmaceuticals in Q3 2014 and held it in 5 quarters.
  • Cheyne Capital Management (UK)'s Aurinia Pharmaceuticals position peaked at $401K in Q1 2015.
  • 16 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q4 2015.

Based on Cheyne Capital Management (UK)'s 13F filing for Q4 2015, filed 15 Jan 2016.